International Society of Glomerular Disease
@isgd.bsky.social
We’re a professional society for glomerular disease experts, founded in 2022.
https://is-gd.org
https://is-gd.org
ASN has shown us the incredible advances being made in glomerular diseases and the opportunities we have to continue improving glomerular science, medicine, and patient care! Join the movement at www.is-gd.org/en/join-isgd
#ISGD #GlomerularDisease #ASNKidneyWeek2025 @tobias-b-huber.bsky.social
#ISGD #GlomerularDisease #ASNKidneyWeek2025 @tobias-b-huber.bsky.social
Join ISGD
Learn more about membership benefits and join the International Society of Glomerular Disease.
www.is-gd.org
November 16, 2025 at 7:49 PM
ASN has shown us the incredible advances being made in glomerular diseases and the opportunities we have to continue improving glomerular science, medicine, and patient care! Join the movement at www.is-gd.org/en/join-isgd
#ISGD #GlomerularDisease #ASNKidneyWeek2025 @tobias-b-huber.bsky.social
#ISGD #GlomerularDisease #ASNKidneyWeek2025 @tobias-b-huber.bsky.social
Post-ASN, the ISGD team visited Galveston and the UTMB campus and team! We chose the venue for the Inaugural 2026 ISGD Clinical Trials Summit. Please save the date: November 12-16, 2026. Stay tuned for more updates on this landmark event! #ClinicalTrials #ISGD @tobias-b-huber.bsky.social
November 16, 2025 at 7:47 PM
Post-ASN, the ISGD team visited Galveston and the UTMB campus and team! We chose the venue for the Inaugural 2026 ISGD Clinical Trials Summit. Please save the date: November 12-16, 2026. Stay tuned for more updates on this landmark event! #ClinicalTrials #ISGD @tobias-b-huber.bsky.social
🌐 Building Our Network - Our ASN reception was a massive success, bringing together over 200 people! It is amazing to see the network we have formed in under three years. It was fantastic to connect with so many of you. #ASN2025 #ISGD #KidneyWeek2025 @tobias-b-huber.bsky.social
November 16, 2025 at 7:46 PM
🌐 Building Our Network - Our ASN reception was a massive success, bringing together over 200 people! It is amazing to see the network we have formed in under three years. It was fantastic to connect with so many of you. #ASN2025 #ISGD #KidneyWeek2025 @tobias-b-huber.bsky.social
Congrats to ISGD Members @ksusztak.bsky.social, @rkramann.bsky.social , Laura Mariani, and @genetickidneydoc.bsky.social on receiving major ASN awards! And congratulations to ISGD members who contributed to this year's amazing scientific content 💡#ISGD #KidneyWeek2025 @tobias-b-huber.bsky.social
November 14, 2025 at 9:45 PM
Congrats to ISGD Members @ksusztak.bsky.social, @rkramann.bsky.social , Laura Mariani, and @genetickidneydoc.bsky.social on receiving major ASN awards! And congratulations to ISGD members who contributed to this year's amazing scientific content 💡#ISGD #KidneyWeek2025 @tobias-b-huber.bsky.social
ISGD had an impactful week at ASN 2025. Big Shout out to Matthias Kretzler ISGD Steering Committee Member and ASN Program Co-Chair, for his leadership in shaping the conference, and for keeping GD at the forefront
#ISGD #ASN2025 #GlomerularDisease #KidneyWeek2025 @tobias-b-huber.bsky.social
#ISGD #ASN2025 #GlomerularDisease #KidneyWeek2025 @tobias-b-huber.bsky.social
November 14, 2025 at 9:41 PM
ISGD had an impactful week at ASN 2025. Big Shout out to Matthias Kretzler ISGD Steering Committee Member and ASN Program Co-Chair, for his leadership in shaping the conference, and for keeping GD at the forefront
#ISGD #ASN2025 #GlomerularDisease #KidneyWeek2025 @tobias-b-huber.bsky.social
#ISGD #ASN2025 #GlomerularDisease #KidneyWeek2025 @tobias-b-huber.bsky.social
Importance of surrogate endpoints - focus on Proteinuria! @ASNKidney
▶️ Proteinuria and Podocyte loss mechanisms 🐙
▶️ Accelerated drug approval 🚀
▶️ A call to Action! by @kirkcampbell - PARASOL results and future expansion 🌟
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ Proteinuria and Podocyte loss mechanisms 🐙
▶️ Accelerated drug approval 🚀
▶️ A call to Action! by @kirkcampbell - PARASOL results and future expansion 🌟
#KidneyWk #ISGDTweets #GlomerularDisease
November 8, 2025 at 9:38 PM
Importance of surrogate endpoints - focus on Proteinuria! @ASNKidney
▶️ Proteinuria and Podocyte loss mechanisms 🐙
▶️ Accelerated drug approval 🚀
▶️ A call to Action! by @kirkcampbell - PARASOL results and future expansion 🌟
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ Proteinuria and Podocyte loss mechanisms 🐙
▶️ Accelerated drug approval 🚀
▶️ A call to Action! by @kirkcampbell - PARASOL results and future expansion 🌟
#KidneyWk #ISGDTweets #GlomerularDisease
Oral Abstract Session 🌟
▶️ The greater the reduction in Proteinuria, the better the outcomes in IgA Nephropathy! 🔑
▶️ Outcomes across diseases and age in the CureGN cohort! 👏
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ The greater the reduction in Proteinuria, the better the outcomes in IgA Nephropathy! 🔑
▶️ Outcomes across diseases and age in the CureGN cohort! 👏
#KidneyWk #ISGDTweets #GlomerularDisease
November 8, 2025 at 12:46 AM
Oral Abstract Session 🌟
▶️ The greater the reduction in Proteinuria, the better the outcomes in IgA Nephropathy! 🔑
▶️ Outcomes across diseases and age in the CureGN cohort! 👏
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ The greater the reduction in Proteinuria, the better the outcomes in IgA Nephropathy! 🔑
▶️ Outcomes across diseases and age in the CureGN cohort! 👏
#KidneyWk #ISGDTweets #GlomerularDisease
Outstandining talk by @AstridWeins on anti-nephrin antibodies
▶️ Anti-nephrin Ab provides diagnostic value, guide treatment and define prognosis
▶️ Refined techniques and appropriate treatment-related timing measurement is crucial 🧪
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ Anti-nephrin Ab provides diagnostic value, guide treatment and define prognosis
▶️ Refined techniques and appropriate treatment-related timing measurement is crucial 🧪
#KidneyWk #ISGDTweets #GlomerularDisease
November 7, 2025 at 10:01 PM
Outstandining talk by @AstridWeins on anti-nephrin antibodies
▶️ Anti-nephrin Ab provides diagnostic value, guide treatment and define prognosis
▶️ Refined techniques and appropriate treatment-related timing measurement is crucial 🧪
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ Anti-nephrin Ab provides diagnostic value, guide treatment and define prognosis
▶️ Refined techniques and appropriate treatment-related timing measurement is crucial 🧪
#KidneyWk #ISGDTweets #GlomerularDisease
Innovative initiatives in Pediatric NS!
▶️ PARASOL provides a regulatory path for new drugs by proving proteinuria as a marker 🌟 and is expanding to APOL-1-mediated KD and MN! 🚀
▶️ NEPTUNE Match moving towards personalized medicine 🎯
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ PARASOL provides a regulatory path for new drugs by proving proteinuria as a marker 🌟 and is expanding to APOL-1-mediated KD and MN! 🚀
▶️ NEPTUNE Match moving towards personalized medicine 🎯
#KidneyWk #ISGDTweets #GlomerularDisease
November 7, 2025 at 9:40 PM
Innovative initiatives in Pediatric NS!
▶️ PARASOL provides a regulatory path for new drugs by proving proteinuria as a marker 🌟 and is expanding to APOL-1-mediated KD and MN! 🚀
▶️ NEPTUNE Match moving towards personalized medicine 🎯
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ PARASOL provides a regulatory path for new drugs by proving proteinuria as a marker 🌟 and is expanding to APOL-1-mediated KD and MN! 🚀
▶️ NEPTUNE Match moving towards personalized medicine 🎯
#KidneyWk #ISGDTweets #GlomerularDisease
Pediatric Nephrotic Syndrome Translational Session
▶️ Diverse Immunological Architecture!
▶️ Recent focus on novel autoantibodies 🎯
▶️ GWAS + composite HLA-PRS in the search of a unified disease mechanism 🧬
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ Diverse Immunological Architecture!
▶️ Recent focus on novel autoantibodies 🎯
▶️ GWAS + composite HLA-PRS in the search of a unified disease mechanism 🧬
#KidneyWk #ISGDTweets #GlomerularDisease
November 7, 2025 at 9:29 PM
Pediatric Nephrotic Syndrome Translational Session
▶️ Diverse Immunological Architecture!
▶️ Recent focus on novel autoantibodies 🎯
▶️ GWAS + composite HLA-PRS in the search of a unified disease mechanism 🧬
#KidneyWk #ISGDTweets #GlomerularDisease
▶️ Diverse Immunological Architecture!
▶️ Recent focus on novel autoantibodies 🎯
▶️ GWAS + composite HLA-PRS in the search of a unified disease mechanism 🧬
#KidneyWk #ISGDTweets #GlomerularDisease
B-cell depleting strategies in lupus nephritis 🐺
▶️ Obinutuzumab confers higher complete remission rates vs other mAbs
▶️ Immunological reset 🆕 CAR-T cells - deeper depletion in varied differentiation stages (for refractory cases!)
#KidneyWk #ISGDtweets #GlomerularDisease
▶️ Obinutuzumab confers higher complete remission rates vs other mAbs
▶️ Immunological reset 🆕 CAR-T cells - deeper depletion in varied differentiation stages (for refractory cases!)
#KidneyWk #ISGDtweets #GlomerularDisease
November 7, 2025 at 8:55 PM
B-cell depleting strategies in lupus nephritis 🐺
▶️ Obinutuzumab confers higher complete remission rates vs other mAbs
▶️ Immunological reset 🆕 CAR-T cells - deeper depletion in varied differentiation stages (for refractory cases!)
#KidneyWk #ISGDtweets #GlomerularDisease
▶️ Obinutuzumab confers higher complete remission rates vs other mAbs
▶️ Immunological reset 🆕 CAR-T cells - deeper depletion in varied differentiation stages (for refractory cases!)
#KidneyWk #ISGDtweets #GlomerularDisease
The role of B-cells in lupus nephritis by @AugustoVaglio 🐺
▶️ B-cell activation and expanison
▶️ B-cell overdifferentiation and hiperreactivity
▶️ Isolated germinal centers
#KidneyWk #ISGDtweets #GlomerularDisease
▶️ B-cell activation and expanison
▶️ B-cell overdifferentiation and hiperreactivity
▶️ Isolated germinal centers
#KidneyWk #ISGDtweets #GlomerularDisease
November 7, 2025 at 8:35 PM
The role of B-cells in lupus nephritis by @AugustoVaglio 🐺
▶️ B-cell activation and expanison
▶️ B-cell overdifferentiation and hiperreactivity
▶️ Isolated germinal centers
#KidneyWk #ISGDtweets #GlomerularDisease
▶️ B-cell activation and expanison
▶️ B-cell overdifferentiation and hiperreactivity
▶️ Isolated germinal centers
#KidneyWk #ISGDtweets #GlomerularDisease
Thrombotic microangiopathy in children - extensive differential @SethiRenalPath!
▶️ From STEC-HUS, TTP to atypical HUS genetics! 🧬
▶️ C3G and DDD involve distinct complement components - ApoE!
▶️ Searching for aHUS specific markers 🔍
#KidneyWk #GlomerularDisease
▶️ From STEC-HUS, TTP to atypical HUS genetics! 🧬
▶️ C3G and DDD involve distinct complement components - ApoE!
▶️ Searching for aHUS specific markers 🔍
#KidneyWk #GlomerularDisease
November 7, 2025 at 6:03 PM
Thrombotic microangiopathy in children - extensive differential @SethiRenalPath!
▶️ From STEC-HUS, TTP to atypical HUS genetics! 🧬
▶️ C3G and DDD involve distinct complement components - ApoE!
▶️ Searching for aHUS specific markers 🔍
#KidneyWk #GlomerularDisease
▶️ From STEC-HUS, TTP to atypical HUS genetics! 🧬
▶️ C3G and DDD involve distinct complement components - ApoE!
▶️ Searching for aHUS specific markers 🔍
#KidneyWk #GlomerularDisease
Membranous Nephropathy is not Adult-exclusive #ASN2025!
▶️ Pediatric patients are not 'little adults' @JeanHouMD - different clinical profiles, many unknown antigens! 🌟
▶️ Hot insights into new pediatric MN antigens @SethiRenalPath - Poster Pearls 👀
#GlomerularDisease
▶️ Pediatric patients are not 'little adults' @JeanHouMD - different clinical profiles, many unknown antigens! 🌟
▶️ Hot insights into new pediatric MN antigens @SethiRenalPath - Poster Pearls 👀
#GlomerularDisease
November 7, 2025 at 5:49 PM
Membranous Nephropathy is not Adult-exclusive #ASN2025!
▶️ Pediatric patients are not 'little adults' @JeanHouMD - different clinical profiles, many unknown antigens! 🌟
▶️ Hot insights into new pediatric MN antigens @SethiRenalPath - Poster Pearls 👀
#GlomerularDisease
▶️ Pediatric patients are not 'little adults' @JeanHouMD - different clinical profiles, many unknown antigens! 🌟
▶️ Hot insights into new pediatric MN antigens @SethiRenalPath - Poster Pearls 👀
#GlomerularDisease
Yesterday's highlights: IgA Nephropathy at Plenary Session!
▶️ 1. Impact of new tools by Dr. Vlado Perkovic - first #ASN2025 publication @kidneyint.bsky.social! 🔥
▶️ 2. Just published @nejm.org - Dr. Richard Lafayette on the ORIGIN 3 trial: Atacicept led to remarkable results! 🤯
#GlomerularDisease
▶️ 1. Impact of new tools by Dr. Vlado Perkovic - first #ASN2025 publication @kidneyint.bsky.social! 🔥
▶️ 2. Just published @nejm.org - Dr. Richard Lafayette on the ORIGIN 3 trial: Atacicept led to remarkable results! 🤯
#GlomerularDisease
November 7, 2025 at 3:28 PM
Yesterday's highlights: IgA Nephropathy at Plenary Session!
▶️ 1. Impact of new tools by Dr. Vlado Perkovic - first #ASN2025 publication @kidneyint.bsky.social! 🔥
▶️ 2. Just published @nejm.org - Dr. Richard Lafayette on the ORIGIN 3 trial: Atacicept led to remarkable results! 🤯
#GlomerularDisease
▶️ 1. Impact of new tools by Dr. Vlado Perkovic - first #ASN2025 publication @kidneyint.bsky.social! 🔥
▶️ 2. Just published @nejm.org - Dr. Richard Lafayette on the ORIGIN 3 trial: Atacicept led to remarkable results! 🤯
#GlomerularDisease
Reposted by International Society of Glomerular Disease
Spreading the word about the Importance and Power of Podocytes at @asnkidney.bsky.social Kidney Week in Houston. @isgd.bsky.social
November 4, 2025 at 8:09 PM
Spreading the word about the Importance and Power of Podocytes at @asnkidney.bsky.social Kidney Week in Houston. @isgd.bsky.social
ASN begins with an inspiring speech from Dr. Prabir Roy-Chaudhury, ASN president. A standing ovation for the new landscape of clinical trials in GD. ISGD is on the ground and will be reporting on the latest in GD. Follow and join the conversation. #ASN2025 #GlomerularDisease
November 6, 2025 at 3:43 PM
ASN begins with an inspiring speech from Dr. Prabir Roy-Chaudhury, ASN president. A standing ovation for the new landscape of clinical trials in GD. ISGD is on the ground and will be reporting on the latest in GD. Follow and join the conversation. #ASN2025 #GlomerularDisease
What an inspiring week at ESPN 2025 in Athens! We’re energized by powerful conversations with pediatric nephrology experts from 57 countries, and grateful to the ESPN team for uniting our global community.
#ESPN2025 #PediatricNephrology #ClinicalTrials #ISGD
#ESPN2025 #PediatricNephrology #ClinicalTrials #ISGD
October 19, 2025 at 6:53 PM
What an inspiring week at ESPN 2025 in Athens! We’re energized by powerful conversations with pediatric nephrology experts from 57 countries, and grateful to the ESPN team for uniting our global community.
#ESPN2025 #PediatricNephrology #ClinicalTrials #ISGD
#ESPN2025 #PediatricNephrology #ClinicalTrials #ISGD
📣 Are you ready for the newest in IgAN?
Join ISGD and Travere Therapeutics on Friday, October 24 at 12:00 PM ET for "PROTECTing What Matters: Targeting Endothelin-1 and Angiotensin II in IgA Nephropathy to Preserve Kidney Function."
Secure your spot: events.zoom.us/ev/AiBA7aMWF...
Join ISGD and Travere Therapeutics on Friday, October 24 at 12:00 PM ET for "PROTECTing What Matters: Targeting Endothelin-1 and Angiotensin II in IgA Nephropathy to Preserve Kidney Function."
Secure your spot: events.zoom.us/ev/AiBA7aMWF...
October 17, 2025 at 1:48 PM
📣 Are you ready for the newest in IgAN?
Join ISGD and Travere Therapeutics on Friday, October 24 at 12:00 PM ET for "PROTECTing What Matters: Targeting Endothelin-1 and Angiotensin II in IgA Nephropathy to Preserve Kidney Function."
Secure your spot: events.zoom.us/ev/AiBA7aMWF...
Join ISGD and Travere Therapeutics on Friday, October 24 at 12:00 PM ET for "PROTECTing What Matters: Targeting Endothelin-1 and Angiotensin II in IgA Nephropathy to Preserve Kidney Function."
Secure your spot: events.zoom.us/ev/AiBA7aMWF...
📢 A TSUNAMI of pediatric kidney clinical trials is upon us! 🌊
At @ESPNSociety in Athens, we kickstarted Time To Train, a Clinical Trialist Bootcamp to inspire the next generation of PIs and demystify the process!
In the golden age of nephrology, no child will be left behind!
At @ESPNSociety in Athens, we kickstarted Time To Train, a Clinical Trialist Bootcamp to inspire the next generation of PIs and demystify the process!
In the golden age of nephrology, no child will be left behind!
October 16, 2025 at 10:38 AM
📢 A TSUNAMI of pediatric kidney clinical trials is upon us! 🌊
At @ESPNSociety in Athens, we kickstarted Time To Train, a Clinical Trialist Bootcamp to inspire the next generation of PIs and demystify the process!
In the golden age of nephrology, no child will be left behind!
At @ESPNSociety in Athens, we kickstarted Time To Train, a Clinical Trialist Bootcamp to inspire the next generation of PIs and demystify the process!
In the golden age of nephrology, no child will be left behind!
The Time to Train team is present at ESPN in Athens, gearing up to educate the upcoming generation of clinical trialists. This timely initiative will serve as a crucial step towards the future of patient care and treatment.
#ESPN2025 #TimeToTrain #ISGD #ClinicalTrials
#ESPN2025 #TimeToTrain #ISGD #ClinicalTrials
October 14, 2025 at 1:26 PM
The Time to Train team is present at ESPN in Athens, gearing up to educate the upcoming generation of clinical trialists. This timely initiative will serve as a crucial step towards the future of patient care and treatment.
#ESPN2025 #TimeToTrain #ISGD #ClinicalTrials
#ESPN2025 #TimeToTrain #ISGD #ClinicalTrials
⛱️ At day 2 of the PARASOL Kickoff, experts united in a commitment to refine trial endpoints in APOL1 kidney disease & MN. A global effort through data sharing and collaboration! www.is-gd.org/en/news-from... #KidneyResearch #Innovation #AMKD #membranousnephropathy #KidneyHealth
Day 2: PARASOL APOL1 & MN Kickoff
PARASOL's day 2 meetings on APOL1 kidney disease and membranous nephropathy focused on biomarker strategies, data sharing, and international collaboration to advance research and clinical trials.
www.is-gd.org
October 13, 2025 at 6:11 PM
⛱️ At day 2 of the PARASOL Kickoff, experts united in a commitment to refine trial endpoints in APOL1 kidney disease & MN. A global effort through data sharing and collaboration! www.is-gd.org/en/news-from... #KidneyResearch #Innovation #AMKD #membranousnephropathy #KidneyHealth
Laura Mariani recapping PARASOL-FSGS project to a full house in Minneapolis as we kick off PARASOL MN and APOL1 projects! (PS we have diagnosed the carpet with Fabry disease) @miktmc.bsky.social @tobias-b-huber.bsky.social @jarcyzphd.bsky.social @utoronto.ca #APOL1nephropathy #MembranousNephropathy
October 10, 2025 at 1:45 AM
Laura Mariani recapping PARASOL-FSGS project to a full house in Minneapolis as we kick off PARASOL MN and APOL1 projects! (PS we have diagnosed the carpet with Fabry disease) @miktmc.bsky.social @tobias-b-huber.bsky.social @jarcyzphd.bsky.social @utoronto.ca #APOL1nephropathy #MembranousNephropathy
PARASOL Project is expanding focus to include biomarkers & endpoints in APOL1 kidney disease and primary MN as well as FSGS. Learn more: eu1.hubs.ly/H0nr8Lv0
@tobias-b-huber.bsky.social @miktmc.bsky.social @jarcyzphd.bsky.social @ohiostatemed.bsky.social @utoronto.ca @nu-nephrology.bsky.social
@tobias-b-huber.bsky.social @miktmc.bsky.social @jarcyzphd.bsky.social @ohiostatemed.bsky.social @utoronto.ca @nu-nephrology.bsky.social
PARASOL Project Expands Focus to APOL1, Membranous Nephropathy
PARASOL Project expands to focus on APOL1 kidney disease and primary membranous nephropathy, aiming to improve clinical trial endpoints for these conditions.
eu1.hubs.ly
October 3, 2025 at 1:26 PM
PARASOL Project is expanding focus to include biomarkers & endpoints in APOL1 kidney disease and primary MN as well as FSGS. Learn more: eu1.hubs.ly/H0nr8Lv0
@tobias-b-huber.bsky.social @miktmc.bsky.social @jarcyzphd.bsky.social @ohiostatemed.bsky.social @utoronto.ca @nu-nephrology.bsky.social
@tobias-b-huber.bsky.social @miktmc.bsky.social @jarcyzphd.bsky.social @ohiostatemed.bsky.social @utoronto.ca @nu-nephrology.bsky.social
Reposted by International Society of Glomerular Disease
Hamburg News: Study by Jan Czogalla & @puellesv.bsky.social & collaborators introduces a metabolically enhanced buffer + perfusion technique - opening a new avenue for kidney transplant organ preservation. @isgd.bsky.social
A technical advance in the field of organ transplantation!
@tobias-b-huber.bsky.social & team develop a metabolite-enhanced perfusion solution that improves kidney transplant viability, testing it across various species, including humans:
buff.ly/FyKsRiE
@tobias-b-huber.bsky.social & team develop a metabolite-enhanced perfusion solution that improves kidney transplant viability, testing it across various species, including humans:
buff.ly/FyKsRiE
September 29, 2025 at 7:59 PM
Hamburg News: Study by Jan Czogalla & @puellesv.bsky.social & collaborators introduces a metabolically enhanced buffer + perfusion technique - opening a new avenue for kidney transplant organ preservation. @isgd.bsky.social